STI-7349 - The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT05978102
 
Jan 16, 2024
 
Next